10.3390/biomedicines8080268 230
PT-141 (On-Demand, ~1/week) Peptide Vials (PT-141, 10 mg each): 8 weeks: 2 vials 12 weeks: 3 vials 16 weeks: 4 vials Insulin Syringes (U-100): 8 weeks: 8 syringes 12 weeks: 12 syringes 16 weeks: 16 syringes Bacteriostatic Water (10 mL bottles): 8 weeks (2 vials 3 mL): 1 bottle 12 weeks (3 vials 3 mL): 1 bottle 16 weeks (4 vials 3 mL): 2 bottles Melanotan II (Daily Loading Maintenance) Peptide Vials (Melanotan II, 10 mg each): 8 weeks: 6 vials 12 weeks: 9 vials 16 weeks: 12 vials Insulin Syringes (U-100): 8 weeks: 56 syringes (7/day 8 weeks) 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): 8 weeks (6 vials 3 mL = 18 mL): 2 bottles 12 weeks (9 vials 3 mL = 27 mL): 3 bottles 16 weeks (12 vials 3 mL = 36 mL): 4 bottles Shared Supplies Alcohol Swabs: One for the vial stopper + one for the injection site each administration
People who suffer from radiculopathy, spondylosis, spinal stenosis, herniated disc, degenerative disc disease, peripheral nerve disorders, spinal cord injury, or other trauma benefit from our collaborative expertise in managing spine disorders
However, there are still a number of drugs currently on the market, where the side effects may potentially outweigh the benefits (e.g., amphetamine derivatives and other centrally active drugs) [28,29]
Not for human or veterinary consumption BAM15 RESEARCH FACTS Units per Bottle: 30 Unit Size: 50 mg Total Active Amount: 1,500 mg Net Volume: 30 ml Compound: N5,N6-Bis(2-fluorophenyl)[2,1,3]oxadiazolo[4,5-b]pyrazine-5,6-diamine (BAM15)
Laboratory studies and in vitro testing have demonstrated that BPC-157 peptide could hold the following benefits: France Research on BPC-157 peptide, also known as the body protection compound, has revealed promising findings across various fields
